Autopsy report · NCT01290523
Yttrium-90 Radioembolization With Glass Microspheres (TheraSphere) for Patients With Hepatocellular Carcinoma
Cause of deathOther
“Off study clinical use of Y90 glass microspheres (TheraSphere)”
Life of this trial
- Registered 9 months after it had already started.
- Ran for about 4 years before it stopped.
- 14 participants enrolled.
- Results were posted on the registry 1 year 3 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- University of California, San Francisco
- Sponsor type
- University, hospital or other
- Conditions
- Hepatocellular Carcinoma
- Interventions
- Selective internal radiation therapy of the liver with Yttrium-90 glass microspheres (TheraSphere)
- Participants
- 14
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.